NCT00964678View on ClinicalTrials.gov

Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Carvedilol

twice daily oral treatment in escalating dose

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Virginia Commonwealth University

OTHER